Sema drug is shorthand for semaglutide. Learn how sema dosing works, what sema 5mg means, and how compounded sema compares with brand-name shots.
"Sema drug" is shorthand for semaglutide, a prescription GLP-1 receptor agonist approved in the United States for type 2 diabetes and chronic weight management. It is sold as Ozempic, Wegovy, and Rybelsus, and it is also made by compounding pharmacies as compounded semaglutide. Semaglutide does not cure diabetes or obesity; it manages blood sugar and appetite while a person keeps taking it under medical supervision.
What Is the Sema Drug?
Semaglutide copies a gut hormone called GLP-1. It slows how fast the stomach empties, raises feelings of fullness, and helps the pancreas release insulin when blood sugar is high.
The drug comes in two main forms:
- Weekly injection — Ozempic and Wegovy, given under the skin with a small needle.
- Daily oral tablet — Rybelsus, taken on an empty stomach with a small amount of water.
All three are FDA-approved, but they are approved for different uses and different maximum doses. A prescriber decides which form fits a patient's health history.
Sema Dosing and the Sema Dosage Chart
Sema dosing always starts low and climbs slowly. The goal is to let the body adjust and to limit nausea, which is the most common side effect.
| Step | Typical weekly dose (injection) | Purpose |
|---|---|---|
| Weeks 1–4 | 0.25 mg | Starter dose; not expected to be therapeutic |
| Weeks 5–8 | 0.5 mg | First step-up |
| Weeks 9–12 | 1 mg | Common diabetes maintenance dose |
| Weeks 13–16 | 1.7 mg | Weight-management titration (Wegovy) |
| Week 17 and beyond | 2.4 mg | Top weight-management dose (Wegovy) |
This sema dosage chart reflects the standard Wegovy titration schedule. Ozempic for diabetes tops out at 2 mg weekly, and Rybelsus is dosed at 3 mg, 7 mg, or 14 mg once daily by mouth.
A sema dosage chart is a starting reference, not a personal prescription. Dose changes should come from the prescribing clinician, and skipping or doubling doses is not safe.
What "Sema 5mg" Really Means
Sema 5mg usually refers to a vial size or the total amount of drug in a compounded vial — not to a single 5 mg injection. Compounded semaglutide is often sold as a 5 mg vial of powder or as a 5 mg/mL solution.
The unit mix-up is a real safety problem. A 5 mg/mL vial drawn to 0.25 mL delivers 1.25 mg, while 25 "units" on an insulin syringe can mean something completely different depending on concentration.
Always confirm the concentration, the prescribed dose in milligrams, and the syringe volume with the pharmacist before the first injection.
Compounded Sema vs. Brand-Name Semaglutide
Compounded sema became popular when brand-name GLP-1 drugs were in shortage and expensive. The two are not interchangeable in terms of regulatory review.
| Product | Form | FDA approval | Typical use |
|---|---|---|---|
| Ozempic | Weekly injection | Approved | Type 2 diabetes |
| Wegovy | Weekly injection | Approved | Chronic weight management |
| Rybelsus | Daily tablet | Approved | Type 2 diabetes |
| Compounded semaglutide | Injection or drops | Not approved | Prescriber-directed |
Compounded semaglutide is not FDA-approved, and compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality. The FDA has also warned about dosing errors with compounded versions.
Compounding rules shift as drug shortages resolve, so patients should check the current status before assuming a compounded product is legally available.
Sema Injection: Side Effects and Drug Interactions
Common side effects of a sema injection include nausea, vomiting, diarrhea, constipation, and stomach pain. These usually ease as the body adjusts to a new dose.
Serious but rare risks include pancreatitis, gallbladder disease, severe gastroparesis, and kidney injury from dehydration. The label also carries a boxed warning about thyroid C-cell tumors seen in rodents, which is why a personal or family history of medullary thyroid cancer or MEN2 is a reason not to use the drug.
Semaglutide drug interactions matter most with insulin and sulfonylureas, since the combination can push blood sugar too low. Because semaglutide slows stomach emptying, it can also change how quickly some oral medications are absorbed.
People exploring other injectable compounds should keep categories separate. The somatropin drug class, for example, works on growth hormone pathways and carries different risks entirely.
Researchers are also studying cagrilintide — the cagri drug — combined with semaglutide under the name CagriSema, which remains experimental. Some online sellers mix semaglutide talk with research peptides such as cjc-1295 with drug affinity complex, but those peptides are not approved for human use and are not substitutes for a prescribed GLP-1 medication.
Cost and Access for Sema
List prices for brand-name semaglutide run roughly $900 to $1,300 per month without insurance. Coverage varies widely, and manufacturer savings cards usually require commercial insurance.
Discount retailer lists rarely help here. A walmart cash price drug list typically covers generics in the $4 to $10 range, and GLP-1 brand products are not included on those lists.
Patients can ask about prior authorization help, manufacturer direct-pay programs, and whether a lower-cost option is appropriate. Any decision to start, stop, or switch sema products should be made with a licensed healthcare professional.
Frequently Asked Questions
Is "sema" the same thing as semaglutide?
Yes. "Sema" is informal shorthand that people use for semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus. Compounded versions sold by compounding pharmacies also contain semaglutide, but they are not FDA-approved products.
What is the starting dose of semaglutide?
The standard starting dose for the injectable form is 0.25 mg once a week for four weeks, followed by a step up to 0.5 mg. That first dose is meant to help the body adjust rather than to produce full effects, and further increases should come from a prescriber.
Is compounded semaglutide as safe as Ozempic or Wegovy?
No. Compounded semaglutide is not FDA-approved, and compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality. The FDA has issued warnings about dosing errors and unapproved ingredients in some compounded GLP-1 products, so patients should discuss any compounded option with a licensed healthcare professional first.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.